News
Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.
2d
News-Medical.Net on MSNHow underreporting masks the real impact of RSV in older populationsResearch shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...
A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, ...
GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results